Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: Results of a multicentric study-Reference-Cited by-同舟云学术

Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: Results of a multicentric study

Published:2011-07 Issue:9 Volume:10 Page:509-513
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Ghillani P.,André C.,Toly C.,Rouquette A.M.,Bengoufa D.,Nicaise P.,Goulvestre C.,Gleizes A.,Dragon-Durey M.A.,Alyanakian M.A.,Chretien P.,Chollet-Martin S.,Musset L.,Weill B.,Johanet C.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Latest update on the Ro/SS-A autoantibody system;Schulte-Pelkum;Autoimmun Rev,2009

2. A 52-kD protein is a novel component of the SS-a/Ro antigenic particle;Ben Chetrit;J Exp Med,1988

3. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen;Chan;J Clin Invest,1991

4. The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms;Frank;Am J Hum Genet,1993

5. The 52000MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures;Rhodes;Immunology,2002

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases;Frontiers in Immunology;2024-08-06

2. Research Progress in pathogenesis of connective tissue disease-associated interstitial lung disease from the perspective of pulmonary cells;Autoimmunity Reviews;2024-07

3. Male patients with primary Sjögren’s syndrome have unique clinical manifestations and circulating lymphocyte profiles;Clinical Rheumatology;2024-04-11

4. Ro52/TRIM21 – From host defense to autoimmunity;Cellular Immunology;2023-11

5. Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study;Arthritis Research & Therapy;2023-09-04